Product Details for NDA 020125
ACCURETIC (HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE)
12.5MG;EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
12.5MG;EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
25MG;EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
12.5MG;EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE
Proprietary Name: ACCURETIC
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG;EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020125
Product Number: 001
Approval Date: Dec 28, 1999
Applicant Holder Full Name: PFIZER PHARMACEUTICALS LTD
Marketing Status: Discontinued
Patent and Exclusivity Information
ACCURETIC (HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE)
Proprietary Name: ACCURETIC
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG;EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020125
Product Number: 001
Approval Date: Dec 28, 1999
Applicant Holder Full Name: PFIZER PHARMACEUTICALS LTD
Marketing Status: Discontinued
Patent and Exclusivity Information
12.5MG;EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE
Proprietary Name: ACCURETIC
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG;EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020125
Product Number: 002
Approval Date: Dec 28, 1999
Applicant Holder Full Name: PFIZER PHARMACEUTICALS LTD
Marketing Status: Discontinued
Patent and Exclusivity Information
ACCURETIC (HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE)
Proprietary Name: ACCURETIC
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 12.5MG;EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020125
Product Number: 002
Approval Date: Dec 28, 1999
Applicant Holder Full Name: PFIZER PHARMACEUTICALS LTD
Marketing Status: Discontinued
Patent and Exclusivity Information
25MG;EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE
Proprietary Name: ACCURETIC
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020125
Product Number: 003
Approval Date: Dec 28, 1999
Applicant Holder Full Name: PFIZER PHARMACEUTICALS LTD
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: ACCURETIC
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N020125
Product Number: 003
Approval Date: Dec 28, 1999
Applicant Holder Full Name: PFIZER PHARMACEUTICALS LTD
Marketing Status: Discontinued
Patent and Exclusivity Information